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The release of quinolone antibiotics in WWTP effluent and surface waters may induce 
bacterial resistance against these and related antibiotics
1-2
 and toxicity to aquatic organisms
3-
4
. Since quinolones are not readily biodegradable, physical-chemical removal technologies 
are indispensable for their removal. This presentation highlights the main insights and 
conclusions that have been gained from a 5-years research
5-10
 (2007-2011) on the ozone-
based advanced oxidation of two antibiotics – ciprofloxacin and levofloxacin – spiked in both 
deionized and hospital WWTP effluent.   
 
Ozonation of both antibiotics was investigated in a temperature controlled bubble reactor 
containing a water volume of 1.75 L. At pH 7 and similar conditions, levofloxacin ozonation 
proved to be faster than that of ciprofloxacin, with half life times of 13 and 16 min, 
respectively. Increasing the ozone inlet concentration (660 - 3680 ppmv) linearly increased 
the ciprofloxacin degradation rate, and fastest degradation occurred at the lowest initial 
ciprofloxacin concentration (23-136 µM). No clear trends were found as a function of 
temperature (6-62°C). For levofloxacin, approximately two times faster ozonation was 
observed at pH 10 compared to pH 3 and 7, while ciprofloxacin degradation was 25 and 10% 
faster at pH 3 compared to pH 7 and 10, respectively.  
 
Based on UV and CID-HRMS analysis of ozonated samples, ten ciprofloxacin and nine  
levofloxacin degradation products were identified, allowing the proposal of reaction path-
ways. Degradation showed to occur at (1) the piperazinyl substituent, (2) the quinolone 
moiety with formation of isatin analogues and (3) the quinolone moiety with formation of 
anthranilic acid analogues. No degradation was observed at the cyclopropyl (ciprofloxacin) or 
oxazinyl group (levofloxacin). Degradation at the quinolone moiety was enhanced at pH 7. 
Since t-butanol addition excluded the formation of isatin and anthranilic acid analogues, the 
necessity of radicals for formation of these products is plausible. At pH 10, deprotonation of 
the N4’-atom of the piperazinyl group enhanced direct ozonation at this site of the molecule. 
Addition of H2O2 to ciprofloxacin and levofloxacin ozonation experiments at pH 7 had only 
limited effect on quinolone degradation, ozone as well as H2O2 consumption, suggesting that 
the radical chain mechanism is of minor importance for quinolone degradation compared to 
direct ozonation. 
 
In hospital WWTP effluent, sorption on suspended solids proved to be important. The largest 
sorption was found at pH 7 which may be linked to the relatively slow ciprofloxacin 
ozonation at this pH. Addition of H2O2 increased ciprofloxacin half life times at pH 7 from 
29 min without H2O2 to 38 min with 1000 µM H2O2, probably due to competition of 
ciprofloxacin with H2O2 for ozone as well as radical species. The residual antibacterial 
activity against P. fluorescens and E. coli seemed mainly determined by the parent compound 
degradation rate. For B. coagulans, however, no difference in antibacterial activity reduction 
was observed as a function of ozonation pH although fastest ozonation was obtained at pH 
10. This suggests that residual antibacterial activity against B. coagulans is also affected by 
differences in reaction products and pathway. 
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